vendredi 31 janvier 2020

Onco Actu du 31 janvier 2020


2.6 ETIOLOGIE - ENVIRONNEMENT



U.S. EPA reaffirms that glyphosate does not cause cancer [Reuters]











3.3 PRÉVENTION - VACCINS



Mass cervical cancer vaccine rollout could save 62 million lives in next 100 years [The Guardian]











4.11 DÉP., DIAG. & PRONO. - OVAIRE



MRI data can predict patient response to treatment and survival in advanced ovarian cancer [Institute of Cancer Research]










4.12 BIOPSIES LIQUIDES



Lung Cancer Liquid Biopsy Study Shows Potential of MRD-Directed Adjuvant Therapy [Genome Web]











5. TRAITEMENTS



Colorectal cancer NICE guideline [NICE]











5.1 TRAITEMENTS - PRÉ-CLINIQUE



Fighting cancer with microbes [Nature]










5.10 TRAITEMENTS - ESSAIS



Researchers develop first international standards for quality of life measurement in cancer [EORTC]










5.12.11 IMMUNOTHÉRAPIES - PRÉ-CLINIQUE



Working to Improve Immunotherapy for Lung Cancer [NIH Director's Blog]










5.12.2 IMMUNOTHÉRAPIES - CAR-T, THÉRAPIES CELLULAIRES



UNC Lineberger discovery would allow researchers to fine-tune activity of cancer-hunting immune cells [UNC]











Penn Researchers Identify Cancer Cell Defect Driving Resistance to CAR T Cell Therapy [Penn Medicine]










5.2 PHARMA



Bayer’s Nubeqa scores key prostate cancer win in battle with Pfizer, J&J [Fierce Pharma]











Josh Bilenker’s team at Eli Lilly chops 3 cancer drug programs in pipeline cleanup as their $1.6B IL-10 effort flames out [EndPoints]











With deals in tow, Roche ends 2019 with five discarded programs [EndPoints]











5.2.3 PHARMA - ÉCONOMIE



Vas Narasimhan wants Novartis to have a big focus on China. Here’s what that looks like [EndPoints]











5.2.6 PHARMA - BIOTECH



Black Diamond’s Upsized IPO Raises $201M to Advance Its Cancer Drug R&D [Xconomy]











Cancer-focused Black Diamond vaults on to Nasdaq in $200M+ public debut, marking biggest biotech IPO in 2020 so far [EndPoints]











6.1 OBSERVATION



U.S. life expectancy slightly rises for first time in four years, due to lower cancer and overdose death rates [STAT]











Late diagnosis of lung cancer hitting survival rate, study says [The Guardian]